Lechosław Turski
#159,243
Most Influential Person Now
Lechosław Turski's AcademicInfluence.com Rankings
Lechosław Turskibiology Degrees
Biology
#12472
World Rank
#15950
Historical Rank
Neuroscience
#2096
World Rank
#2154
Historical Rank
Download Badge
Biology
Why Is Lechosław Turski Influential?
(Suggest an Edit or Addition)Lechosław Turski's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. (1999) (2015)
- Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study (1983) (1066)
- Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? (2002) (660)
- Long‐Term Effects of Pilocarpine in Rats: Structural Damage of the Brain Triggers Kindling and Spontaneous I Recurrent Seizures (1991) (632)
- Review: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: A novel experimental model of intractable epilepsy (1989) (623)
- Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists (1991) (566)
- Autoimmune encephalomyelitis ameliorated by AMPA antagonists (2000) (485)
- Seizures produced by pilocarpine in mice: A behavioral, electroencephalographic and morphological analysis (1984) (362)
- The susceptibility of rats to pilocarpine-induced seizures is age-dependent. (1987) (298)
- NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats (1990) (290)
- The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine‐depleted rats and MPTP‐treated monkeys (1991) (249)
- Spontaneous Recurrent Seizures in Rats: Amino Acid and Monoamine Determination in the Hippocampus (1994) (239)
- N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. (1999) (226)
- Neuronal death enhanced by N-methyl-D-aspartate antagonists. (2000) (203)
- Expression of glutamate receptor subunits in human cancers (2009) (176)
- Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease (1989) (170)
- Glutamate antagonists limit tumor growth. (2002) (168)
- Glutamate antagonists limit tumor growth (2001) (154)
- Glutamate Receptor Expression in Multiple Sclerosis Lesions (2008) (154)
- Toward an understanding of the role of glutamate in experimental parkinsonism: Agonist‐sensitive sites in the basal ganglia (1993) (142)
- Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: Effects of intranigral 2-amino-7-phosphonoheptanoate and n-methyl-d-aspartate (1986) (140)
- ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. (1998) (135)
- NMDA antagonist inhibits the extracellular signal-regulated kinase pathway and suppresses cancer growth (2005) (131)
- Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease (1991) (131)
- Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors. (1990) (131)
- Antiepileptic drugs and brain development (2010) (126)
- Cholinomimetics produce seizures and brain damage in rats (1983) (123)
- Sedative and anticonvulsant drugs suppress postnatal neurogenesis (2008) (118)
- Multiple Sclerosis and Glutamate (2003) (113)
- Susceptibility to seizures produced by pilocarpine in rats after microinjection of isonnazid or γ-vinyl-GABA into the substantia nigra (1986) (107)
- Diazepam dependence prevented by glutamate antagonists. (1993) (100)
- Muscle relaxant action of excitatory amino acid antagonists (1985) (100)
- Glutamate: a new target in schizophrenia? (1990) (99)
- Dopamine-sensitive anticonvulsant site in the rat striatum (1988) (99)
- Antiepileptic drugs and the developing brain (2006) (98)
- Seizures produced by pilocarpine: Neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain (1986) (96)
- Only certain antiepileptic drugs prevent seizures induced by pilocarpine (1987) (94)
- Paradoxical anticonvulsant activity of the excitatory amino acid N-methyl-D-aspartate in the rat caudate-putamen. (1987) (94)
- Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit. (2005) (93)
- Dopamine control of seizure propagation: Intranigral dopamine D1 agonist SKF‐38393 enhances susceptibility of seizures (1990) (88)
- Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio. (1990) (84)
- Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline. (1992) (83)
- Neurodegenerative disorders: clues from glutamate and energy metabolism. (1996) (83)
- Effects of aminophylline and 2-chloroadenosine on seizures produced by pilocarpine in rats: Morphological and electroencephalographic correlates (1985) (81)
- Excitotoxicity and neurodegenerative diseases. (1995) (80)
- N‐メチル‐D‐アスパラギン酸きっ抗薬と発達ラット脳における頭部外傷により引き起こされるアポトーシス細胞死 (1999) (77)
- The seizures induced by pilocarpine: behavioral, electroencephalographic and neuropathological studies in rodents. (1987) (75)
- Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: An electroencephalographic, behavioural and morphological analysis (1985) (73)
- Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. (1993) (66)
- Muscle relaxant and anticonvulsant activity of 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-d-aspartate antagonist, in rodents (1987) (65)
- Fluoxetine inhibits the extracellular signal regulated kinase pathway and suppresses growth of cancer cells (2008) (65)
- GABAergic mechanisms in mediating muscular rigidity, catalepsy and postural asymmetry in rats: Differences between dorsal and ventral striatum (1984) (61)
- Differential effects of antiepileptic drugs and β-carbolines on seizures induced by excitatory amino acids (1990) (60)
- Intrastriatal N-methyl-d-aspartate prevents amygdala kindled seizures in rats (1986) (58)
- Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline. (1996) (53)
- The basal ganglia, the deep prepyriform cortex, and seizure spread: bicuculline is anticonvulsant in the rat striatum. (1989) (52)
- The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist (1993) (52)
- Effects of excitatory amino-acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydantoin in mice. (1984) (50)
- Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions. (1996) (49)
- Long-term treatment with abecarnil does not induce diazepam-like dependence in mice. (1993) (47)
- Anticonvulsant action of β-kainic acid in mice. Is β-kainic acid an N-methyl-d-aspartate antagonist? (1985) (45)
- Role of opioid receptors in the substantia nigra in morphine-induced muscular rigidity. (1982) (45)
- The rat ventromedial thalamic nucleus and motor control: role of N- methyl-D-aspartate-mediated excitation, GABAergic inhibition, and muscarinic transmission (1986) (43)
- AhR and IDO1 in pathogenesis of Covid-19 and the “Systemic AhR Activation Syndrome:” a translational review and therapeutic perspectives (2020) (42)
- Microinjections of the γ-aminobutyrate antagonist, bicuculline methiodide, into the caudate-putamen prevent amygdala-kindled seizures in rats (1987) (42)
- Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice (1990) (41)
- Nigral GABAergic mechanisms and EMG activity in rats: differences between pars reticulata and pars compacta. (1983) (39)
- AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth (2007) (39)
- Prevention of trauma-induced neurodegeneration in infant and adult rat brain: Glutamate antagonists (1996) (38)
- The role of the substantia nigra in motility of the rat Muscular rigidity, body asymmetry and catalepsy after injection of morphine into the nigra (1983) (37)
- Intrahippocampal bethanechol in rats: Behavioural, electroencephalographic and neuropathological correlates (1983) (37)
- Substantia nigra regulates action of antiepileptic drugs (1990) (35)
- Anticonvulsant activity of two novel piperazine derivatives with potent kainate antagonist activity (1985) (33)
- Blockade of excitatory neurotransmission in the globus pallidus induces rigidity and akinesia in the rat: implications for excitatory neurotransmission in pathogenesis of Parkinson's diseases (1990) (33)
- Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats (1988) (33)
- Alprazolam dependence prevented by substituting with the β-carboline abecarnil (1997) (33)
- Phosphonic analogues of excitatory amino acids raise the threshold for maximal electroconvulsions in mice (1985) (32)
- Effects of the antiparkinsonian drug budipine on central neurotransmitter systems. (1996) (30)
- Evidence that antagonism at non-NMDA receptors results in anticonvulsant action. (1987) (30)
- Paradoxical convulsant action of a novel non-competitiveN-methyl-d-aspartate (NMDA) antagonist, tiletamine (1988) (30)
- MPTP-induced degeneration: interference with glutamatergic toxicity. (1994) (28)
- Glutamate receptors in laryngeal cancer cells. (2011) (27)
- Convulsant action of morphine, [d-ala2, d-leu5]-enkephalin and naloxone in the rat amygdala: Electroencephalographic, morphological and behavioural sequelae (1987) (27)
- Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology (1993) (27)
- Inhibition of cisplatin-induced emesis in ferrets by the non-NMDA receptor antagonists NBQX and CNQX (1992) (27)
- Effect of Aminophylline and Enprofylline on the Protective Efficacy of Common Antiepileptic Drugs Against Electroconvulsions in Mice (1987) (26)
- Paradoxical anticonvulsant acitivity of the γhyphen;Aminobutyrate antagonist bicuculline methiodide in the rat striatum (1991) (26)
- ZK 91296, an anticonvulsant β-carboline which lacks muscle relaxant properties (1985) (25)
- Evidence for functional interactions of morphine in substantia nigra and striatum in relation to muscular rigidity in rats (1982) (25)
- Some cannabinoid receptor ligands and their distomers are direct-acting openers of SUR1 K(ATP) channels. (2012) (24)
- Distinct sites of functional interaction between dopamine, acetylcholine and γ-aminobutyrate within the neostriatum: An electromyographic study in rats (1986) (24)
- Neurochemical changes in the hippocampus of rats with spontaneous recurrent seizures. (1992) (23)
- Diphenylhydantoin potentiates the protective effect of diazepam against pentylenetetrazol but not against bicuculline and isoniazid-induced seizures in mice (1981) (23)
- Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam. (1993) (22)
- Motor actions of excitatory amino acids and their antagonists within the rat ventromedial thalamic nucleus (1986) (21)
- Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane (2004) (21)
- Substantia nigra and motor control in the rat: effect of intranigral α-kainate and γ-d-glutamylaminomethylsulphonate on motility (1987) (21)
- Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration. (2005) (20)
- Disturbed GABAergic transmission in mutant Han-Wistar rats: Further evidence for basal ganglia dysfunction (1985) (19)
- Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation. (1993) (19)
- Prevention of kainic acid-induced seizure-like activity by antiepileptic drugs. (1980) (19)
- Disinhibition of nigral GABA output neurons mediates muscular rigidity elicited by striatal opioid receptor stimulation. (1982) (18)
- Effects of 2-chloroadenosine on amygdaloid and hippocampal kindled seizures. (1985) (18)
- Kindling to the benzodiazepine receptor inverse agonist, FG 7142: Evidence for involvement of NMDA, but not non-NMDA, glutamatergic receptors (1993) (18)
- (RS)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: Wet dog shakes, catalepsy and body temperature changes in rats (1981) (18)
- Does the pentylenetetrazole (PTZ) cue reflect PTZ‐induced kindling or PTZ‐induced anxiogenesis? (1989) (17)
- Anticonvulsant action of stereoisomers of γ-glutamylaminomethylsulphonic acid in mice (1985) (17)
- Mechanisms of Disease: Motoneuron Disease Aggravated by Transgenic Expression of a Functionally Modified AMPA Receptor Subunit (2005) (16)
- Anticonvulsant role of adenosine. (1987) (16)
- Role of GABAergic mechanisms in the substantia nigra pars reticulata in modulating morphine-induced muscular rigidity in rats (1982) (16)
- Effects of morphine and naloxone on pilocarpine-induced convulsions in rats (1985) (16)
- What are the differences between abecarnil and conventional benzodiazepine anxiolytics? (1992) (15)
- Kainic acid-induced wet dog shakes in rats (1980) (14)
- Myorelaxant effect after intrathecal injection of antispastic drugs in rats (1989) (13)
- Effect of aminophylline on muscle relaxant action of diazepam and phenobarbitone in genetically spastic rats: further evidence for a purinergic mechanism in the action of diazepam. (1984) (13)
- Intraamygdaloid morphine produces seizures and brain damage in rats. (1983) (13)
- Reversal of the muscle relaxant effect of diazepam but not of progabide by a specific benzodiazepine antagonist: Ro 15-1788. (1983) (13)
- Is the muscle relaxant effect of diazepam in spastic mutant rats mediated through GABA-independent benzodiazepine receptors? (1983) (13)
- Alprazolam dependence prevented by substituting with the beta-carboline abecarnil. (1997) (13)
- Catalepsy after microinjection of haloperidol into the rat medial prefrontal cortex (2004) (12)
- Effects of combined treatment with diphenylhydantoin and different benzodiazepines on pentylenetetrazoland bicuculline-induced seizures in mice (1982) (12)
- Effects of kainic acid on body temperature of rats: Role of catecholaminergic and serotonergic systems (2004) (12)
- Excitatory Amino Acids and Anxiety (1991) (11)
- Phosphonate quinoxalinedione AMPA antagonists. (2000) (11)
- Intrathecal Injection of Antispastic Drugs in Rats: Muscle Relaxant Action of Midazolam, Baclofen, 2-Aminophosphonoheptanoic Acid (AP7) and Tizanidine (1988) (11)
- CGS 8216, Ro 15-1788 and methyl-beta-carboline-3-carboxylate, but not EMD 41717 antagonize the muscle relaxant effect of diazepam in genetically spastic rats. (1984) (11)
- Unusual interactions of excitatory amino acid receptor agonists: α- and β-kainate antagonize motor responses to N-methyl-d-aspartate in rodents (1987) (11)
- A specific benzodiazepine antagonist CGS 8216 reverses the muscle relaxant effect of diazepam but not that of phenobarbitone. (1984) (11)
- [The N-methyl-D-aspartate receptor complex. Various sites of regulation and clinical consequences]. (1990) (11)
- Effects of methyl beta-carboline-3-carboxylate, Ro 15-1788 and CGS 8216 on muscle tone in genetically spastic rats. (1985) (11)
- The role of striatal cholinergic mechanisms for the development of limb rigidity: An electromyographic study in rats (1986) (11)
- δ-Aminovaleric acid antagonizes the pharmacological actions of baclofen in the central nervous system (2004) (10)
- Modification of the anticonvulsant activity of 2-amino-5-phosphonovalerate by agents affecting different neurotransmitter systems (1985) (10)
- Studies on the mechanism of wet dog shakes produced by carbachol in rats. (1984) (10)
- Stereotypy, locomotor and cataleptic effects produced by drugs influencing dopaminergic systems in a mutant strain of wistar rats: A genuine model of basal ganglia dysfunction? (1984) (10)
- Induction of wet dog shakes by intracerebroventricular bethanechol in rats. Antagonism by neurotransmitter receptor blockers. (1982) (10)
- On the possible role of excitatory amino acids in the striatum in mediating morphine-induced muscular rigidity (1982) (10)
- Evidence that opioid receptors in the substantia nigra pars reticulata are relevant in regulating the function of striatal efferent pathways (1982) (10)
- N-Methyl-D-aspartate antagonists stimulate locomotor activity in monoamine depleted rats: Implications for the therapy of Parkinson’s disease (1990) (10)
- Biochemical consequences of kainic acid injection into the lateral brain ventricle in rat. (1981) (10)
- Neurotransmitters in the Basal Ganglia and Motor Thalamus: Their Role for the Regulation of Muscle Tone (1987) (9)
- Pharmacology of the AMPA Antagonist 2,3‐Dihydroxy‐6‐Nitro‐7‐Sulfamoylbenzo‐(F)‐Quinoxaline (1997) (9)
- Substantia nigra and entopeduncular nucleus: supraspinal sites of the muscle relaxant action of tizanidine (1986) (9)
- Effect of combined treatment of phenytoin with diazepam on the susceptibility of mice to electroconvulsions (1981) (8)
- Rigidity and catalepsy after injections of muscimol into the ventromedial thalamic nucleus: an electromyographic study in the rat (2004) (7)
- Glutamate in Neurodegenerative Disorders: Phenotype Resulting from Decreased Expression of AMPA Receptor GIuR-B Subunit mRNA in Rats (1998) (7)
- The involvement of catecholaminergic mechanisms in the appearance of wet dog shakes produced by carbachol chloride in rats. (1982) (7)
- Studies of carbachol-induced wet-dog shake behavior in rats (2004) (7)
- Muscle relaxant action of phenobarbitone in genetically spastic rats: an electromyographic study. (1986) (6)
- Evidence against the involvement of serotonergic mechanisms in wet dog shake behavior induced by carbachol chloride in rats (2004) (5)
- Excitatory Amino Acids and Second Messenger Systems (1991) (5)
- Muscle relaxant action of 2-chloroadenosine in genetically spastic rats is independent of γ-aminobutyric acid-mediated inhibition (1985) (5)
- Interaction between phenytoin and diazepam in mutant Han-Wistar rats with progressive spastic paresis (1982) (5)
- Reversal of the muscle relaxant effect of diazepam by the specific benzodiazepine antagonist Ro 15-1788: an electromyographic study in morphine model of muscular rigidity in rats. (1983) (5)
- Atropine reversal of kainic acid‐induced decrease in the leptazol convulsive threshhold (1981) (5)
- The entopeduncular nucleus regulates muscle tone in genetically spastic rats: role of substance P and γ-aminobutyric acid (1990) (5)
- Substantia nigra and motor control in the rat: effect of intranigral alpha-kainate and gamma-D-glutamylaminomethylsulphonate on motility. (1987) (5)
- The locomotor and exploratory activities in rats after lesion of hippocampal pyramidal cells with kainic acid. (1980) (5)
- Are changes in glutamatergic mechanisms responsible for kindling to the benzodiazepine receptor inverse agonist, FG 7142? (1989) (4)
- Excitatory Amino Acids (1998) (4)
- Role of muscarinic cholinergic mechanisms in the substantia nigra pars reticulata in mediating muscular rigidity in rats (1984) (4)
- Abstracts of the International Symposium Excitatory Amino Acids "Ten Years Later" held in Manaus, Brazil on November 1922, 1998 (1998) (4)
- Excitatory amino acids : from genes to therapy (1998) (4)
- Dyphenylhydantoin enhancement of diazepam effects on locomotor activity in mice (2004) (4)
- The threshold for limbic seizures in rats is decreased by intranigral morphine. (1986) (4)
- Bilateral injection of kainic acid into the rat striatum potentiates morphine, arecoline and pilocarpine but not haloperidol catalepsy. (1982) (4)
- Anticonvulsant action of stereoisomers of gamma-glutamylaminomethylsulphonic acid in mice. (1985) (3)
- Tolerance to and Dependence on Alprazolam are Due to Changes in GABAa Receptor Function and Are Independent of Exposure to Experimental Set-up. (1998) (3)
- Convulsant action of pentetrazol in rats with selective lesions of the hippocampal pyramidal cells with intracerebroventricular kainic acid. (1982) (3)
- Effect of antidepressant drugs on carbachol chloride-induced wet dog shake behaviour in rats (1981) (2)
- Energy Failure, Glutamate and Neuropathology: Relevance to Neurodegenerative Disorders (1994) (2)
- Shuttle behavior in rats after lesion of hippocampal pyramidal cells with kainic acid. (1981) (2)
- Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist? (1985) (2)
- Effect of trazodone, mianserin, iprindole and zimelidine on wet dog shakes produced by carbachol in rats (1981) (2)
- Questions and Answers (2003) (2)
- 6-aminovaleric acid antagonizes the pharmacological actions of baclofen in the central nervous system (1)
- Convulsant action of naloxone in the rat amygdala. (1986) (1)
- Anticancer Effects of Glutamate Antagonists (2005) (1)
- Electrophysiological and behavioural evidence that abecarnil suppresses dependence symptoms after alprazolam withdrawal in mice: 16.11 (1995) (1)
- A more expansive interpretation (1987) (1)
- Seizures Induced by Pilocarpine: Relevance in Epilepsy (1992) (1)
- Energia i my (1997) (1)
- Effects of morphine, nalorphine and morphine withdrawal on lethal toxicity of intracerebroventricular kainic acid in mice. (1981) (1)
- Neurodegenerative Diseases: Excitoxicity and excitatory amino acid antagonists in chronic neurodegenerative diseases (2005) (1)
- Does morphine withdrawal produce brain damage in rats? (1983) (1)
- ZK 91296, an anticonvulsant beta-carboline which lacks muscle relaxant properties. (1985) (1)
- New kinoksaliinidionijohdannaisia, their preparation and the use of drugs (1995) (0)
- The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats. (1981) (0)
- Phthalazine derivatives, their preparation and use as medicaments (1996) (0)
- [The influence of atropine on the antiamphetaminic action of fluphenazine (author's transl)]. (1979) (0)
- Imidazole derivative, its preparation and antipsychotic agent containing the same (1988) (0)
- Pyrido (1,2,3-de) quinoxaline derivatives, processes for their preparation and their use of drugs (1993) (0)
- Fundamental Mechanisms of Human Brains Function Edited by Jerome Engel Jr, George A. Ojemann, Hans O. Lüders and Peter D. Williamson. ISBN 088167-311-0. Price: $41.50. Raven Press, New York, 1986 (1988) (0)
- Excitatory Amino Acids: Approaches to Rational Anticonvulsant Therapy (1986) (0)
- Is it time to conclude that NMDA antagonists have failed? – Author's reply (2003) (0)
- Frontiers in excitatory amino acid research : proceedings of an International Symposium "Excitatory Amino Acids '88," held in Manaus, Amazonas, Brazil, March 28-April 2, 1988 (1988) (0)
- The glutamatergic system in multiple sclerosis and experimental autoimmune encephalomyelitis (2002) (0)
- Long-term effects on the developing brain through a brief alteration of NMDA or GABAA receptor mediated neurotransmission (2008) (0)
- M Journal of Neural Transmission Synergism of the Ampa-antagonist Nbqx and the Nmda-antagonist Cpp with L-dopa in Models of Parkinson's Disease (0)
- New use of NMDA receptor antagonists (1989) (0)
- Kinoxalin derivatives such deras framstaellning Science anvaendning i laekemedel (1993) (0)
- Production of preventive for chronic neurodegenerative disease and agent containing effective amount of antagonist against nmda-receptor complex material (1990) (0)
- Excitatory amino acids in neurodegenerative disorders: glutamate and energy metabolism (1995) (0)
- Reply (1990) (0)
- 3-aryl- or 3-hetaryl (beta) carbolines, their production and use in pharmaceutical compositions (1991) (0)
- Quinoxalinedione new derivatives, their preparation and use in medicaments. (1994) (0)
- Questions and answers: Session VI: Neuroprotective agents and mechanisms (2005) (0)
- Effects of morphine and nalorphine on kainic acid-induced hypothermia in rats (2004) (0)
- Effect of glutamic acid diethylester on (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and kainic acid-induced changes of body temperature in rats. (1982) (0)
- Drugs to prevent the development of tolerance during treatment with benzodiazepine receptor-binding agents (1992) (0)
- Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzoLf)quinoxaline (brain injury/glutamate antagonists/therapeutic time-window) (2016) (0)
- Benzo (f) kinoksaliinidionijohdannaisia, their preparation and their use as medicaments (1995) (0)
- New ss-carboline, process for their preparation and their use in medicinal products (1989) (0)
- Behavioral and eeg changes induced by systemic pilocarpine in developing rats (1985) (0)
- E-Education. Remarks of the Professional (2006) (0)
- Delta-aminovaleric acid antagonizes the pharmacological actions of baclofen in the central nervous system. (1988) (0)
- Present and Future Significance of ADMET Profiling in Industrial Drug Research (2007) (0)
- New (beta) -carbolinderivate whose production and use in pharmaceuticals (1991) (0)
- Effects of ZK 93426 on withdrawal syndrome following chronic alprazolam in mice: 16.10 (1995) (0)
- Unusual interactions of excitatory amino acid receptor agonists: alpha- and beta-kainate antagonize motor responses to N-methyl-D-aspartate in rodents. (1987) (0)
- Pyrido (1,2,3-de) quinoxaline, process for their production and their use in medicaments. (1994) (0)
- Drugs for treatment of withdrawal symptoms (1991) (0)
- THER PRODUCTION AND USE IN PHARMACEUTICAL AGENTS (2017) (0)
- N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain ( traumatic head injury y apoptosis y necrosis y excitotoxicity y neurodegeneration ) (1999) (0)
- Using μ-carbolines as non-competitive glutamate antagonists (1992) (0)
- Drugs for the prevention of tolerance development during the treatment with benzodiazepine-receptor-binding active ingredients (1993) (0)
- Benzo (f) quinoxalinedione, their preparation and their use in medicine. (1994) (0)
- Pyrido (1,2,3-de) quinoxaline derivatives, process for their preparation and to their use as medicaments (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lechosław Turski?
Lechosław Turski is affiliated with the following schools:
